1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Wearable Injector Market, by Type
6.1. Introduction
6.2. Body Worn Patch Injector
6.3. Off Body Worn Patch Injector

7. Wearable Injector Market, by Application
7.1. Introduction
7.2. Autoimmune Disease
7.3. Cardiovascular Disease
7.4. Diabetes
7.5. Infectious Disease
7.6. Oncology

8. Wearable Injector Market, by End Use
8.1. Introduction
8.2. Clinic
8.3. Home Care Setting
8.4. Hospital
8.5. Online Pharmacy
8.6. Retail Pharmacy
8.7. Specialty Clinics

9. California Wearable Injector Market

10. Florida Wearable Injector Market

11. Illinois Wearable Injector Market

12. New York Wearable Injector Market

13. Ohio Wearable Injector Market

14. Pennsylvania Wearable Injector Market

15. Texas Wearable Injector Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Amgen Inc.
17.2. BASF SE
17.3. Becton, Dickinson and Company
17.4. DCA Design International Ltd
17.5. E3D Elcam Drug Delivery Devices
17.6. Gerresheimer AG
17.7. Insulet Corporation
17.8. Johnson & Johnson
17.9. Medtronic PLC
17.10. Neuma LLC
17.11. SCHOTT AG
17.12. SONCEBOZ SA
17.13. Stevanato Group S.p.A.
17.14. Valeritas, Inc.
17.15. West Pharmaceutical Services, Inc.
17.16. Ypsomed AG

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES WEARABLE INJECTOR MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES WEARABLE INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES WEARABLE INJECTOR MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2026
FIGURE 7. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 12. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2026
FIGURE 14. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY DIABETES, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY END USE, 2020 VS 2026 (%)
FIGURE 25. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY END USE, 2020 VS 2026 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY END USE, 2026
FIGURE 27. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY CLINIC, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES WEARABLE INJECTOR MARKET: FPNV POSITIONING MATRIX
FIGURE 40. UNITED STATES WEARABLE INJECTOR MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 41. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES WEARABLE INJECTOR MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES WEARABLE INJECTOR MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES WEARABLE INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES WEARABLE INJECTOR MARKET: SCORES
TABLE 21. UNITED STATES WEARABLE INJECTOR MARKET: BUSINESS STRATEGY
TABLE 22. UNITED STATES WEARABLE INJECTOR MARKET: PRODUCT SATISFACTION
TABLE 23. UNITED STATES WEARABLE INJECTOR MARKET: RANKING
TABLE 24. UNITED STATES WEARABLE INJECTOR MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 25. UNITED STATES WEARABLE INJECTOR MARKET: MERGER & ACQUISITION
TABLE 26. UNITED STATES WEARABLE INJECTOR MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 27. UNITED STATES WEARABLE INJECTOR MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 28. UNITED STATES WEARABLE INJECTOR MARKET: INVESTMENT & FUNDING
TABLE 29. UNITED STATES WEARABLE INJECTOR MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 30. UNITED STATES WEARABLE INJECTOR MARKET: LICENSE & PRICING

Companies Mentioned

Amgen Inc.
BASF SE
Becton, Dickinson and Company
DCA Design International Ltd
E3D Elcam Drug Delivery Devices
Gerresheimer AG
Insulet Corporation
Johnson & Johnson
Medtronic PLC
Neuma LLC
SCHOTT AG
SONCEBOZ SA
Stevanato Group S.p.A.
Valeritas, Inc.
West Pharmaceutical Services, Inc.
Ypsomed AG